Wall Street Analysts Predict a 28.56% Upside in Bio-Rad (BIO): Here's What You Should KnowZacks Investment Research • 03/10/23
Bio-Rad to Participate in Citi's 2023 Healthcare Services, MedTech, Tools & HCIT ConferenceBusiness Wire • 02/17/23
Element Biosciences and Bio-Rad Partner to Deliver Seamless RNA Sequencing Workflow Between Element's AVITI™ System and Bio-Rad's SEQuoia™ Express and SEQuoia™ Complete Stranded RNA Library Prep KitsPRNewsWire • 02/08/23
Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023Business Wire • 01/06/23
Bio-Rad: How Efficient Is Its Capital Management? A Deep Look, With TechnicalsSeeking Alpha • 01/04/23
Bio-Rad to Present Company Overview at J.P. Morgan 41st Annual Healthcare ConferenceBusiness Wire • 01/04/23
These Are the Five Best and Worst Performing Healthcare Stocks in October 202224/7 Wall Street • 11/29/22
These Were The Five Best And Worst Performing Large-Cap Stocks in October 202224/7 Wall Street • 11/09/22
Bio-Rad To Participate in Fireside Chat During Credit Suisse's 31st Annual Healthcare ConferenceBusiness Wire • 10/31/22
Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022Business Wire • 10/17/22
Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks UnlikelyInvestors Business Daily • 10/11/22
Bio-Rad and German-based biotech Qiagen weighing latest tie-up in medical-diagnostic marketMarket Watch • 10/11/22